Literature DB >> 33278080

The role of the molecular circadian clock in human energy homeostasis.

Lucile Dollet1, Logan A Pendergrast2, Juleen R Zierath1,2,3.   

Abstract

PURPOSE OF REVIEW: The aim of this review is to present the latest findings on the role of the circadian clock in the control of metabolism, and the therapeutic potential of chronotherapy to regulate energy homeostasis in humans. RECENT
FINDINGS: We summarized the recent advances related to circadian clock regulation of food intake and energy expenditure. In peripheral organs, mitochondrial oxidative capacity and lipolysis show circadian pattern in humans, and rhythms disruption may be involved in the pathogenesis of metabolic diseases. Indeed, circadian desynchrony affects food intake, insulin sensitivity, and increases the risk of developing metabolic disease. Time-targeted strategies, which aim to synchronize external cues with the molecular clock to improve metabolic outcomes, have positive effects on metabolism in humans, with several studies showing that time-targeted feeding improves body weight loss and glucose tolerance.
SUMMARY: The interest in time-targeted strategies to prevent or manage metabolic disturbances has grown this past year with encouraging health benefits. To maximize the therapeutic effect of these strategies, further research is warranted to delineate the molecular regulation of metabolic processes controlled by the clock and especially its modulation in contexts such as aging, sex differences, or metabolic diseases.
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 33278080     DOI: 10.1097/MOL.0000000000000722

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  1 in total

1.  Metabolic state switches between morning and evening in association with circadian clock in people without diabetes.

Authors:  Ruriko Fujimoto; Ysuharu Ohta; Konosuke Masuda; Akihiko Taguchi; Masaru Akiyama; Kaoru Yamamoto; Hiroko Nakabayashi; Yuko Nagao; Takuro Matsumura; Syunsuke Hiroshige; Yasuko Kajimura; Makoto Akashi; Yukio Tanizawa
Journal:  J Diabetes Investig       Date:  2022-05-18       Impact factor: 3.681

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.